Postprandial human triglyceride-rich lipoproteins increase chemoattractant protein secretion in human macrophages

Cytokine

Volumn 63, Issue 1, 2013, Pages 18-26

  Napolitano, Mariarosaria ^a   Botham, Kathleen M ^b   Bravo, Elena ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Arachidonic acid cascade; Atherosclerosis; Dietary lipoprotein; Human monocyte derived macrophages; Monocyte chemoattractant protein 1 (MCP 1)

Indexed keywords

ARACHIDONIC ACID; CHEMOATTRACTANT; CHEMOKINE; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIPOXIN A; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; POSTPRANDIAL TRIGLYCERIDE RICH LIPOPROTEIN; PROSTAGLANDIN; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPOLYSIS; MACROPHAGE FUNCTION; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; UPREGULATION;

ADULT; ARACHIDONIC ACID; CHEMOTAXIS; EXTRACELLULAR SPACE; FATTY ACIDS; FEMALE; HUMANS; INFLAMMATION; LIPOLYSIS; LIPOPROTEINS; MACROPHAGES; MALE; MONOCYTE CHEMOATTRACTANT PROTEINS; MONOCYTES; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 84878913773     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.04.025     Document Type: Article

References (52)

1. Redgrave T.G. Formation and metabolism of chylomicrons. Int Rev Physiol 1983, 28:103-130.
2. Cooper A.D. Hepatic uptake of chylomicron remnants. J Lipid Res 1997, 38:2173-2192.
3. Bravo E., Napolitano M., Botham K.M. Postprandial lipid metabolism: the missing link between life-style habits and the increasing incidence of metabolic diseases in western countries?. Open Transl Med J 2010, 2:1-13.
4. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298:309-316.
5. Yu K.C., Cooper A.D. Postprandial lipoproteins and atherosclerosis. Front Biosci 2001, 6:D332-354.
6. Kadar A., Glasz T. Development of atherosclerosis and plaque biology. Cardiovasc Surg 2001, 9:109-121.
7. Hyson D., Rutledge J.C., Berglund L. Postparandial lipemia and cardiovascular disease. Curr Atheroscler Rep 2003, 5:437-444.
8. Alipour A., Elte J.W.F., van Zaanen H.C.T., Rietveld A.P., Castro Cabezas M. Novel aspects of postprandial lipemia in relation to atherosclerosis. Atheroscler Suppl 2008, 9:39-44.
9. Wilhelm M.G., Cooper A.D. Induction of atherosclerosis by human chylomicron remnants: a hypothesis. J Atheroscler Thromb 2003, 10:132-139.
10. Proctor S.D., Vine D.F., Mamo J.C.L. Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis. Curr Opin Lipidol 2002, 13:461-470.
11. Proctor S.D., Mamo J.C.L. Intimal retention of cholesterol derived from apolipoprotein B100 and apolipoprotein b48containing lipoproteins in carotid arteries of watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 2003, 23:1595-1600.
12. Pal S., Semorine K., Watts G.F., Mamo J.C.L. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med 2003, 41:792-795.
13. Rapp J., Lespine A., Hamilton R., Colyvas N., Chaumeton A., Tweedie-Hardman J., et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti- apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb Vasc Biol 1994, 14:1767-1774.
14. Botham K.M., Bravo E., Elliott J., Wheeler-Jones C.P. Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development. Curr Pharm Des 2005, 11:3681-3695.
15. Botham K.M., Moore E.H., Pascale C., Bejta F. The induction of macrophage foam cell formation by chylomicron remnants. Biochem Soc Trans 2007, 35:454-458.
16. Bentley C., Hathaway N., Widdows J., Bejta F., De Pascale C., Avella M., et al. Influence of chylomicron remnants on human monocyte activation in vitro. Nutr Metab Cardiovasc Dis 2011, 21:871-878.
17. Norata G.D., Grigore L., Raselli S., Seccomandi P.M., Hamsten A., Maggi F.M., et al. Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: molecular mechanisms andgene expression studies. J Mol Cell Cardiol 2006, 40:484-494.
18. Wheeler-Jones C.P.D. Chylomicron remnants: mediators of endothelial dysfunction?. Biochem Soc Trans 2007, 35:442-445.
19. Samuelsson B., Dahlén S.E., Lindgren J.A., Rouzer C.A., Serhan C.N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987, 237:1171-1176.
20. Yang C., Liu X., Cao Q., Liang Q., Qiu X. Prostaglandin E receptors as inflammatory therapeutics targets for atherosclerosis. Life Sci 2011, 88:201-205.
21. Ford-Hutchinson A.W. Leukotriene B4 in inflammation. Crit Rev Immunol 1990, 10:1-12.
22. Chait A., Iverius P.H., Brunzell J.D. Lipoprotein lipase secretion by human monocyte-derived macrophages. J Clin Invest 1982, 62:490-493.
23. Jackson K.G., Robertson M.D., Fielding B.A., Frayn K.N., Williams C.M. Measurement of apolipoprotein B-48 in the Svedberg flotation rate (S(f))400, S(f) 60-400 and S(f) 20-60 lipoprotein fractions reveals novel findings with respect to the effects of dietary fatty acids on triacylglycerol-rich lipoproteins in postmenopausal women. Clin Sci 2002, 103:227-237.
24. Napolitano M., Bravo E. Activation of protein kinase C by phorbol esters in human macrophages reduces the metabolism of modified LDL by down-regulation of scavenger receptor activity. Int J Biochem Cell Biol 2003, 35:1127-1143.
25. Dhadwal H.S., Ansari R.R., Meyer W.V. A fiber-optic probe for particle sizing in concentrated suspensions. Rev Sci Instrum 1991, 62:2963-2968.
26. Napolitano M., Bravo E. Evidence of dual pathways for lipid uptake during chylomicron remnant-like particle processing by human macrophages. J Vasc Res 2006, 43:355-366.
27. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
28. Gamble W., Vaughan M., Kruth H.S., Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res 1978, 19:1068-1070.
29. Mendez A.J., Cabeza C., Hsia S.L. A fluorometric method for the determination of triglycerides in nanomolar quantities. Anal Biochem 1986, 156:386-389.
30. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
31. Bravo E., Cantafora A., Marinelli T., Avella M., Mayes P.A., Botham K.M. Differential effects of chylomicron remnants derived from corn oil or palm oil on bile acid synthesis and very low density lipoprotein secretion in cultured rat hepatocytes. Life Sci 1996, 59:331-337.
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 45:1-29.
33. Palmer A.M., Nova E., Anil E., Jackson K., Bateman P., Wolstencroft E., et al. Differential uptake of subfractions of triglyceride-rich lipoproteins by THP-1 macrophages. Atherosclerosis 2005, 180:233-244.
34. Hasham S.N., Pillarisetti S. Vascular lipases, inflammation and atherosclerosis. Clin Chim Acta 2006, 372:179-183.
35. Skarlatos S., Dichek H., Fojo S., Brewer H., Kruth H. Absence of triglyceride accumulation in lipoprotein lipase-deficient human monocyte-macrophages incubated with human very low density lipoprotein. J Clin Endocrinol Metab 1993, 76:793-796.
36. Hakkinen T., Luoma J.S., Hiltunen M.O., Macphee C.H., Milliner K.J., Patel L., et al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999, 19:2909-2917.
37. Yeaman S.J. Hormone-sensitive lipase-new roles for an old enzyme. Biochem J 2004, 379:11-22.
38. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001, 21:1876-1890.
39. De Pascale C., Avella M., Perona J.S., Ruiz-Gutierrez V., Wheeler-Jones C.P.D., Botham K.M. Fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages. FEBS J 2006, 273:5632-5640.
40. Cox-York K., Sharp T.A., Stotz S.A., Bessesen D.H., Pagliassotti M.J., Horton T.J. The effects of sex, metabolic syndrome and exercise on postprandial lipemia. Metabolism 2013, 62:244-254.
41. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009, 29:313-326.
42. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. New Engl J Med 2006, 354:610-621.
43. Norata G.D., Catapano A.L. Triglyceride-rich lipoproteins from normotrygliceridemic subjects and hyperlipidemic patients differently affect endothelial cell activation and gene expression patterns. Circ Res 2007, 100:e81.
44. Graham V., Lawson C., Wheeler-Jones C., Perona J., Ruiz-Gutierrez V., Botham K.M. Triacylglycerol-rich lipoproteins derived from healthy donors fed different olive oils modulate cytokine secretion and cyclooxygenase-2 expression in macrophages: the potential role of oleanolic acid. Eur J Nut 2012, 51:301-309.
45. De Pascale C., Graham V., Fowkes R.C., Wheeler-Jones C.P.D., Botham K.M. Suppression of nuclear factor-κB activity in macrophages by chylomicron remnants: modulation by the fatty acid composition of the particles. FEBS J 2009, 276:5689-5702.
46. Graham V.S., Di Maggio P., Armengol S., Lawson C., Wheeler-Jones C.P.D., Botham K.M. Inhibition of macrophage inflammatory cytokine secretion by chylomicron remnants is dependent on their uptake by the low density lipoprotein receptor. Biochim Biophys Acta 1811, 2011:209-220.
47. Ueda A., Okuda K., Ohno S., Shirai A., Igarashi T., Matsunaga K., et al. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994, 153:2052-2063.
48. Saraswathi V., Hasty A.H. The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages. J Lipid Res 2006, 47:1406-1415.
49. Gimbrone M.A., Brock A.F., Schafer A.L. Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J Clin Invest 1984, 74:1552-1555.
50. Maddox J.F., Serhan C.N. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 1996, 183:137-146.
51. Serhan C.N., Takano T., Gronert K., Chiang N., Clish C.B. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators. Clin Chem Lab Med 1999, 37:299-309.
52. Lee C., Sigari F., Segrado T., Horkko S., Hama S., Subbaiah P.V., et al. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified: modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase. Arterioscler Thromb Vasc Biol 1999, 19:1437-1446.